10-QPeriod: Q2 FY2013

UNITEDHEALTH GROUP INC Quarterly Report for Q2 Ended Jun 30, 2013

Filed August 5, 2013For Securities:UNH

Summary

UnitedHealth Group reported solid revenue growth of 12% for the first six months of 2013 compared to the same period in 2012, reaching $60.7 billion. This growth was primarily driven by acquisitions, expansion in the number of individuals served, and robust performance across its Optum businesses. Despite strong revenue top-line performance, net earnings attributable to common shareholders saw a slight decrease of 4% to $2.6 billion for the first six months, largely due to a change in business mix favoring government programs, Medicare and Medicaid funding pressures, and less favorable medical cost development compared to the prior year. The company's balance sheet remains strong, with total assets of $80.2 billion and shareholders' equity of $31.4 billion as of June 30, 2013. The company continues to navigate a complex regulatory environment, particularly concerning Medicare Advantage funding reductions and the upcoming health insurance tax under the Affordable Care Act. Management is focused on adapting to these changes through cost management, network adjustments, and strategic participation in new market opportunities like health insurance exchanges. The Optum platform, encompassing health services, insights, and pharmacy benefits, demonstrated significant growth, with revenues increasing by 21% for the quarter and 18% year-to-date, highlighting its increasing importance to the company's overall performance.

Financial Statements
Beta
Revenue$30.41B
Cost of Revenue$669.00M
Gross Profit$29.74B
SG&A Expenses$4.83B
Operating Expenses$28.01B
Operating Income$2.40B
Interest Expense$176.00M
Net Income$1.44B
EPS (Basic)$1.42
EPS (Diluted)$1.40
Shares Outstanding (Basic)1.01B
Shares Outstanding (Diluted)1.03B

Key Highlights

  • 1Consolidated revenues increased by 12% to $60.7 billion for the first six months of 2013, driven by acquisitions and Optum's growth.
  • 2Net earnings attributable to common shareholders decreased by 4% to $2.6 billion for the first six months of 2013, impacted by business mix shifts and Medicare/Medicaid funding pressures.
  • 3UnitedHealthcare membership grew by 9.1 million people, largely due to international expansion and TRICARE contract, while commercial risk-based membership declined.
  • 4Optum segment revenues surged by 21% in the second quarter and 18% year-to-date, indicating strong performance across its health services, insights, and pharmacy businesses.
  • 5The company actively repurchased shares, buying back 23 million shares for $1.3 billion in the first six months of 2013, and increased its quarterly dividend.
  • 6UnitedHealth Group maintains a strong liquidity position with $7.7 billion in cash and cash equivalents and $19.6 billion in investments as of June 30, 2013.
  • 7The company is proactively managing regulatory pressures, including Medicare Advantage rate reductions and the upcoming Affordable Care Act industry tax, by focusing on cost containment and strategic market participation.

Frequently Asked Questions

Revenue growth was primarily driven by acquisitions, notably the increased ownership in Amil, expansion in the number of individuals served across its UnitedHealthcare platforms (including international and TRICARE contracts), and strong organic growth within the Optum businesses (OptumHealth, OptumInsight, and OptumRx).

The decrease in net earnings was influenced by a shift in business mix towards government programs with potentially lower margins, ongoing pressure on Medicare and Medicaid funding rates, and a decrease in favorable medical cost development compared to the exceptionally high levels seen in the first half of 2012. The conversion of a large client from risk-based to fee-based arrangements also impacted revenue recognition.

UnitedHealth Group is implementing several strategies, including intensifying medical and operating cost management, adjusting care provider network contracts and benefits, carefully selecting market participation, and focusing on improving quality scores to maximize Medicare star ratings for potential bonuses. The company is also incorporating projected costs of the Affordable Care Act industry tax into its 2013 rate filings where applicable.

The Optum segment continues to be a key growth engine for UnitedHealth Group. Its revenue growth in the first half of 2013 was substantial, driven by pharmacy benefit management (OptumRx), clinical services (OptumHealth), and health information technology solutions (OptumInsight). This demonstrates the company's successful diversification into higher-margin information and technology-enabled health services.